Provided by Tiger Trade Technology Pte. Ltd.

CUTIA-B

1.950
-0.220-10.14%
Volume:633.40K
Turnover:1.25M
Market Cap:727.35M
PE:-1.89
High:2.170
Open:2.170
Low:1.900
Close:2.170
52wk High:12.000
52wk Low:1.900
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:7.79
T/O Rate:0.17%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.030
ROE:-36.58%
ROA:-14.29%
PB:0.70
PE(LYR):-1.89
PS:1.85

Loading ...

Cutia Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend

Bulletin Express
·
Aug 19

Cutia Therapeutics (HKG:2487): Are Analysts Optimistic?

Simply Wall St.
·
Aug 11

CUTIA-B Issues 9.803 Million Shares Under Share Scheme

Stock News
·
Jul 02

Cutia Therapeutics Next-day Disclosure Return Reports 9,803,014 New Shares Issued on HKEX

Reuters
·
Jul 02

Cutia Therapeutics Secures Full Shareholder Support at 2026 AGM, Obtains Fresh Issue and Buy-back Mandates

Bulletin Express
·
Jun 26

Cutia Therapeutics AGM Resolutions Passed in Shareholder Vote

Reuters
·
Jun 26

CUTIA-B Records HK$91.56 Million Share Transfer, Representing 7.07% of Holdings

Stock News
·
Jun 05

Cutia Therapeutics Holds Share Base Steady in May 2026, Confirms Sufficient Public Float

Bulletin Express
·
Jun 04

CUTIA-B Keeps Share Count Flat in April; 230,110 Options and 2.06 Million Share Awards Forfeited

Bulletin Express
·
May 07

CUTIA-B (02487) Receives NMPA Approval for CU-30101, a Topical Lidocaine-Tetracaine Cream

Stock News
·
May 07

Cutia-B obtains NMPA marketing nod for CU-30101 lidocaine-tetracaine topical anesthetic

Bulletin Express
·
May 07

Cutia Therapeutics says NMPA approves CU-30101 topical lidocaine-tetracaine cream

Reuters
·
May 07

Cutia Therapeutics - Cu-30101 Obtains Drug Marketing Authorization by Nmpa in China

THOMSON REUTERS
·
May 07

Fidelity China Fund Boosts Stake in Cutia-B with 30,600 Share Purchase

Stock News
·
Apr 28

Cutia Therapeutics Updates Cayman Registrar Name to Ascentium (Cayman) Limited

Bulletin Express
·
Apr 27

Cutia Therapeutics 2025年度简讯:收入同比增20.2%至3.362亿人民币,核心皮肤科产品商业化显著提升业绩

Bulletin Express
·
Apr 24

Cutia Posts RMB336.20 Million Revenue; ESG Drive Cuts Carbon Intensity 16.67 %

Bulletin Express
·
Apr 24

CUTIA-B schedules 26 Jun 2026 AGM to approve board renewals, 10% buyback and 20% issuance mandates

Bulletin Express
·
Apr 24

Cutia Therapeutics announces annual general meeting

Reuters
·
Apr 24

Cutia Therapeutics publishes 2025 annual report

Reuters
·
Apr 24